BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8763259)

  • 21. Histopathologic findings in chronic hepatitis C.
    Fischer HP; Willsch E; Bierhoff E; Pfeifer U
    J Hepatol; 1996; 24(2 Suppl):35-42. PubMed ID: 8836887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B.
    Shah HA; Kayani N; Sheikh H; Jafri SW; Hamid S; Khan AH
    Indian J Gastroenterol; 1995 Jul; 14(3):91-4. PubMed ID: 7544766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of histological features in chronic hepatitis C.
    Jármay K; Karácsony G; Ozsvár Z; Nagy I; Lonovics J; Schaff Z
    Hepatogastroenterology; 2002; 49(43):239-43. PubMed ID: 11941964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of interferon therapy on bile duct inflammation in hepatitis C.
    Banner BF; Allan C; Smith L; Savas L; Bonkovsky HL
    Virchows Arch; 1996 Jul; 428(4-5):253-9. PubMed ID: 8764934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.
    Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G
    Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen DRB1 1302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C.
    Haruna Y; Miyamoto T; Yasunami R; Kanda T; Fushimi H; Kotoh K
    J Hepatol; 2000 May; 32(5):837-42. PubMed ID: 10845672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An evaluation of the degree of the morphological activity and the stage of the process in patients with chronic liver diseases caused by coinfection with the hepatitis B, C and/or D viruses].
    Siutkin VE; Lopatkina TN; Popova IV
    Arkh Patol; 1998; 60(6):37-41. PubMed ID: 9949904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of steatosis with fibrosis and necro-inflammation in chronic hepatitis C infection in the absence of confounding factors.
    Zubair A; Mubarik A; Jamal S; Arif A; Khan DA
    J Coll Physicians Surg Pak; 2009 Jul; 19(7):417-20. PubMed ID: 19576148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults.
    Assy N; Minuk GY
    Am J Gastroenterol; 2000 Jun; 95(6):1545-50. PubMed ID: 10894594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.
    Hepatology; 1994 Jul; 20(1):15-20. PubMed ID: 8020885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.
    Zaitoun AM; Al Mardini H; Awad S; Ukabam S; Makadisi S; Record CO
    J Clin Pathol; 2001 Jun; 54(6):461-5. PubMed ID: 11376020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia.
    Monteverde A; Ballarè M; Pileri S
    Springer Semin Immunopathol; 1997; 19(1):99-110. PubMed ID: 9266634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current anatomico-pathological classification of hepatitis: characteristics of HCV infection.
    Mosnier JF
    Nephrol Dial Transplant; 1996; 11 Suppl 4():12-5. PubMed ID: 8918744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.
    Gadd VL; Melino M; Roy S; Horsfall L; O'Rourke P; Williams MR; Irvine KM; Sweet MJ; Jonsson JR; Clouston AD; Powell EE
    Liver Int; 2013 Apr; 33(4):569-79. PubMed ID: 23240894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathologic impact of GB virus C infection on chronic hepatitis C.
    Bralet MP; Roudot-Thoraval F; Pawlotsky JM; Bastie A; Tran Van Nhieu J; Duval J; Dhumeaux D; Zafrani ES
    Gastroenterology; 1997 Jan; 112(1):188-92. PubMed ID: 8978358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.
    Nguyen Canh H; Harada K; Ouchi H; Sato Y; Tsuneyama K; Kage M; Nakano M; Yoshizawa K; Takahashi A; Abe M; Kang JH; Koike K; Inui A; Fujisawa T; Takaki A; Arinaga-Hino T; Torimura T; Suzuki Y; Fujiwara K; Zeniya M; Ohira H; Tanaka A; Takikawa H;
    J Clin Pathol; 2017 Nov; 70(11):961-969. PubMed ID: 28428284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR expression in bile duct damage in hepatitis C.
    Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN
    Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation.
    Gaweco AS; Wiesner RH; Porayko M; Rustgi VK; Yong S; Hamdani R; Harig J; Chejfec G; McClatchey KD; Van Thiel DH
    Hepatology; 2000 May; 31(5):1183-91. PubMed ID: 10796896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathologic observations of hepatitis C].
    Liu X; Wang T; Zheng L
    Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):292-5. PubMed ID: 8745476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
    Schneider AR; Teuber G; Kriener S; Caspary WF
    Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.